The first possibility is the difference in seizure sensitivity
regimens and larger sample sizes are necessary. Tumor-based assays require well-preserved biopsy material, are technically difficult, incur substantial costs, and have a slow turnaround time. By contrast, the MALDI-TOF-MS method…